The circulating biomarkers league: combining miRNAs with cell-free DNAs and proteins

K Felekkis, C Papaneophytou - International Journal of Molecular …, 2024 - mdpi.com
The potential of liquid biopsy for the prognosis and diagnosis of diseases is unquestionable.
Within the evolving landscape of disease diagnostics and personalized medicine, circulating …

Circulating microRNAs for early diagnosis of ovarian cancer: a systematic review and meta-analysis

NLS Frisk, AE Sørensen, OBV Pedersen, LT Dalgaard - Biomolecules, 2023 - mdpi.com
In this study, we conducted a systematic review and meta-analysis to summarize and
evaluate the global research potential of different circulating miRNAs as an early diagnostic …

A novel circulating miRNA panel for non-invasive ovarian cancer diagnosis and prognosis

AW Gahlawat, T Witte, L Haarhuis, S Schott - British journal of cancer, 2022 - nature.com
Background Ovarian cancer (OC) is an aggressive disease, primarily diagnosed in late
stages with only 20% of patients surviving more than 5 years after diagnosis. There is a …

m6A target microRNAs in serum for cancer detection

B Zhang, Z Chen, B Tao, C Yi, Z Lin, Y Li, W Shao… - Molecular Cancer, 2021 - Springer
Recent studies have revealed the significant dysregulation of m 6 A level in peripheral blood
in several cancer types and its value in diagnosis. Nonetheless, a biomarker for accurate …

High-grade serous ovarian cancer—A risk factor puzzle and screening fugitive

J Wilczyński, E Paradowska, M Wilczyński - Biomedicines, 2024 - mdpi.com
High-grade serous ovarian cancer (HGSOC) is the most lethal tumor of the female genital
tract. Despite extensive studies and the identification of some precursor lesions like serous …

Identification of driver genes and miRNAs in ovarian cancer through an integrated in-silico approach

A Beg, R Parveen, H Fouad, ME Yahia, AS Hassanein - Biology, 2023 - mdpi.com
Simple Summary Ovarian cancer ranks among the most frequent causes of death in women
since the prognosis is greatly influenced by the disease's stage. Since ovarian cancer is …

[HTML][HTML] Differential circulating MicroRNA expression in age-related macular degeneration

H ElShelmani, I Brennan, DJ Kelly… - International journal of …, 2021 - mdpi.com
This study explored the expression of several miRNAs reported to be deregulated in age-
related macular degeneration (AMD). Total RNA was isolated from sera from patients with …

Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of bioinformatics data

CMT Tran, PS Dinh - Journal of Biomolecular Structure and …, 2024 - Taylor & Francis
Cancer is the second most common cause of mortality worldwide, accounting for almost 10
million deaths in 2020. These deaths were partly due to delayed diagnosis that led to …

[HTML][HTML] Circulating microRNAs as Diagnostic Biomarkers to Detect Specific Stages of Ovarian Cancer: A Comprehensive Meta-Analysis

AER Kartikasari, P Michel-Lara, H Exton, K Tekin-Sari… - Cancers, 2024 - mdpi.com
Background: Ovarian cancer (OC) remains the deadliest gynecological malignancy, despite
significant treatment advances. The absence of early detection tests results in advanced …

[PDF][PDF] Understanding the Impact of Oxidative Stress on Ovarian Cancer: Advances in Diagnosis and Treatment

Y Meshkovska, A Abramov, S Mahira… - Future …, 2024 - preprints.org
Ovarian cancer (OC) ranks as the fifth most common cancer among women in the United
States and globally, posing a significant health threat. Reactive oxygen species (ROS) have …